A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients

Completed · Not applicable

Conditions studied: MRSA Colonization

In brief

Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in hospital settings. Colonization with MRSA puts patients at increased risk for invasive infections, and MRSA infections have been associated with high costs and adverse clinic outcomes. Patients can clear MRSA spontaneously. Improved approaches for identifying patients who are no longer colonized are needed; we hypothesize that more sensitive nucleic acid amplification can be used to improve identification of patients who are no longer colonized.

Key facts

Study ID

NCT01234831

Run by

Massachusetts General Hospital

People needed

463

Starts

2010-12-01

Expected to finish

2016-03-01

Last updated by the study team

2017-10-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age > 18
• last positive MRSA culture greater than 3 months old
• admitted to hospital

You may not qualify if…

• age < 18
• last positive MRSA culture less than or equal to 3 months old

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.